Bolt Biotherapeutics, Inc. (BOLT) Revenue & EPS Growth Rates 2026 | EvidInvest

Growth Analysis - BOLT

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth0.07%

5Y CAGR101.61%

10Y CAGRN/A

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth75.61%

5Y CAGR-53.36%

10Y CAGRN/A

Equity

1Y Growth-53.66%

5Y CAGRN/A

10Y CAGRN/A

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	0.1%	-1.2%	10.3%	101.6%	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	-2.4%	15.9%	82.7%	104.5%	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	37.5%	150.0%	224.3%	N/A	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	354.7%	398.0%	198.7%	N/A	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	445.5%	142.1%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	7.4%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2019 Dec 31, 2019	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2018 Dec 31, 2018	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - BOLT

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Bolt Biotherapeutics, Inc.

Compare with peers

Explore

Growth Analysis - BOLT

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Bolt Biotherapeutics, Inc.

Compare with peers

Explore